Back to News
Market Impact: 0.25
Revolution Medicines, Inc. (RVMD) Reports Q3 Loss, Beats Revenue Estimates
Source: zacks.com
Corporate EarningsHealthcare & Biotech
Revolution Medicines reported a quarterly loss of $1.90 per share, narrower than the Zacks Consensus Estimate of a $2.34 loss. The loss widened from $1.61 per share a year earlier.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mixed
Sentiment Score
0.10
Ticker Sentiment
RVMD0.40
More News
- Qualcomm issues disappointing earnings forecast as memory shortage weighs on smartphone sales
- ‘Seismic’ blue wave triggers the sinking of oil prices, energy stocks, and the chances of power permitting reform
- Nifty Bounces Back to Beat All of Asia on Foreign Flows, Earnings
- Snap shares fall over 10% on third-quarter earnings miss
- What Democrats’ midterm sweep means for your investments
- A blue wave sends futures into the green